After this educational event, attendees should be able to:
Please Note: All session times are listed in Gulf Standard Time (GST).
To view the PDF version of the Scientific Programme, please click here.
To view a list of unmoderated ePosters, please click here.
To view a list of moderated and residents’ forum ePosters, please consult the Scientific Programme for those sessions.
0800-1000
SYMP-02: Pan-African Urological Surgeons Association (PAUSA) Symposium
SESSION I: Minimally Invasive Urologic Surgery
What Urologist Needs to Know About Endourologic Equipment Before Urinary Stone Treatment?
Laparoscopy in Urology: Perspectives in Africa
Developing Endourology in Africa, the Nigerian Experience with “NAUS- Karl Storz Endourology Roadshow’
Q&A
SESSION II: General Urology
Epidemiology and Types of Urinary Lithiasis in Senegal
Antibiotics Resistance Pattern in Urology Patients in Western Kenya
Maintaining a Scientific Basis Is Essential for Contemporary Urological Practice
Q&A
0800-1000
SYMP-03: International Society of Reconstructive Urology (ISORU) Symposium
Introduction
Fossa Navicularis Stricture
Non Transection Bulbar Urethroplasty
2 Stage BMG Urethroplasty
Strictures in Africa
Expert Comments/ Q&A
Setting up a Congenitilism Unit
Demographics of Urethral Stricture
Roaming Reconstructive Urologist
Hypospadias Fistula
Reaching 100 cases after Fellowship
Expert Comments/ Q&A
Closing Remarks
0830-1200
SYMP-01: 9th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)
Opening SANTU-9
Moderated Posters
SANTU Lectures
Practical Endourology for the Global Surgeon
How to Help Medical Technology Development in Low-income Countries
How to Create a Frugal Innovation
The Way to Affordable Innovation
Affordability Session
The Unmet Need: The Genesis of the Idea
How do We Develop the Cost-effective Innovations into a Product?
Conundrum of Regulatory and Patent-related Issues: Developing Countries vs. Developed Countries
How Can the Innovator Safeguard his Interest (Financial and Intellectual Property-related)?
Q&A
4th Best Affordable New Technologies in Urology Contest (BANTUC)
Presentation of 4th BANTUC
Presentation of the Projects by the Finalist List
Reconstructed 20 mL Syringe Evacuator as an Alternative to Bladder Syringe/Ellick Evacuator for Clot Retention Evacuation in Rural Communities
Cheap and Accessible 3D Printed Metal Dilators for Low-resource Settings
Ash bag: A Simple Remedy in the Management for Urine Leak
Laparoscopic Port Lithotripter: An Affordable and Low Cost New Technique for Pneumatic Stone Destruction
Q&A
Announcement of the Results and Awards Distribution of 4th BANTUC & Invitation to 5th BANTUC
Closing SANTU-9 and Invitation to SANTU-10, 2022
0900-1200
SYMP-04: Indian Urology Around the World Symposium
Welcome Address
Overcoming Challenging Problems during Flexible Ureteroscopy
Dust or Bust: A Beginners Guide to Modern Day Laser Lithotripsy Srategies for Ureteroscopy
Tips & Tricks in Urologic Surgery (Semi-Live)
Ureteroscopy
PCNL
SECOND OPINION : How to Manage a 65-year old Man with Bothersome LUTS due to BPE with Underactive Detrusor
New Techniques of Treating BPH – Are They Far from Practical Reality...!?
Nocturia in Elderly Male - Continuing Dilemma
The Imaging Gap in Stone Disease - Whose Fault Is It?
Black Pearls Session: Complications in Laparoscopy & Robotic Urologic Surgery
Controversies in Surgical Stone Management: A Case Based Discussion
Concluding Remarks
1000-1210
SYMP-05: Society of Genitourinary Reconstructive Surgeons (GURS) Symposium
Introduction
TOPIC A: Male and Female Lower Urinary Tract (LUT) Reconstruction
Challenges in the Management of LUT Trauma
Therapeutic Challenges in Female Genitourinary Fistulae
Difficult Urethral Strictures in Complex Settings (Lichen Sclerosus, Iatrogenic, and Radiation-Induced)
Female Urethroplasty: Any Evidence-Based Guidelines for Treatment?
Q&A
TOPIC B: Troubleshooting Complications in Genitourinary Reconstruction: Learning from Our Mistakes
Failed PFUI Repair
Options for Failed Ureteric Reconstruction
Failure of Recurrent Surgical Treatment for Post-Prostatectomy Incontinence: What Next?
When Further Reconstruction is Futile in Irradiated Pelvis: The Case for Urinary Diversion
Q&A
TOPIC C: Challenges in Penile Prosthesis Implantation
Following Penile Fracture and Trauma
Penile Implantation in Transmen
Following Prior IPP Infection-Erosion
Q&A
Closing Remarks
1300-1520
SYMP-06: Joint SIU-Chinese Urological Association (ChUA) Symposium
Bladder Infections
Treatment Strategies in Recurrent UTI
Treatment of UTI in Pediatric Cases
Biofilm and its Implications in Urology
Bladder Cancer NMIBC
Image 1S, NBI or PDD – Which One to Use?
Why Should You do En-bloc Resection?
Bladder Cancer MIBC
Uretero-enteric strictures following radical Cystectomy
Chemotherapy in MIBC: When and How?
Upper Tract Urothelial Cancer
Indications and Outcomes of Conservative Treatment
Preventive Strategies of Bladder Recurrence Following UTUC Treatment
Closing Remarks
1300-1510
SYMP-08: Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA) Symposium
Welcome
Use of Buccal Mucosal Graft to Repair Complex Hypospadias as Two Stage Procedure - Review of First Sixty Cases
The Influence of Covid-19 Pandemic on Accessibility to TURBT Among Bladder Cancer Patients Seen at Kenyatta National Hospital, Nairobi
Public and Private Partnership in Maximizing Teaching in Urology During the Covid Era
Genetics of Prostate Cancer
Prostate Cancer Age-Standardized Incidence Increase Between 2006 and 2016 in Gauteng Province, South Africa: A Laboratory Data-Based Analysis
An Update on Percutaneous Nephrolithotomy
Misplaced DJ Stent Dislodged After A-H Pyeloplasty in 15-Year Old Male
Discussion
Take Home Message
1500-1645
SYMP-11: Symposium on Focal Therapy
Learning Objective: Following this session, attendees will be able to foster a FT session in both renal and prostate cancer to further improve the understanding of an organ-sparing approach.
Introduction
We Identify the Index Lesion with pMRI: Current Limitations of pMRI in the Evaluation of Prostate Cancer
Micro-ultrasound Guided Biopsies: Dismissing or Adding Value to mpMRI?
Transitioning from MRI Fusion Biopsy to Focal Therapy
Focal Therapy for PCa: What Is Really Needed to Move from Investigational to Valid Therapeutic Alternative?
Tumour Microenvironment and Focal Therapy for Prostate Cancer: Are We Missing Something?
Post-Focal Therapy Assessment: Biopsy and Salvage Options after Focal Therapy Recurrence
Conclusion
0730-0900
SYMP-07: Urological Association of Asia (UAA) Symposium
Welcome and Introduction
Part 1: Urolithiasis
Simulated Training in Endourology
Prolonging Life of Flexible Ureteroscopes
1.5cm Upper Ureteric Stone; What’s Best in Asia?
PCNL
Laparoscopy
Part 2: Advanced Urological Malignancies
Precision Medicine in Prostate Cancer
Decreasing Complications of Radical Cystectomy
Cost Matters when Using Advanced Therapies for Cancer
Part 3: Andrology and Infertility
PRP for Erectile Dysfunction
Managing Peyronie’s Disease in 2021
Fertility Issues in Boys with Cancers
Take Home Message
0730-0850
SYMP-10: Joint SIU-Korean Urological Association (KUA) Symposium
Welcome Address by KUA and SIU President
Endourology
No Touch Technique in Ureteroscopy
Hand-Assisted Laparoscopic Surgery (HALS) in Urology: Is it Still Alive?
ECIRS: Indications, Tips and Tricks
Oncology
Partial Nephrectomy: When Open and When Laparoscopic/Robotic
Pediatrics & Voiding Dysfunction
OAB Medical Treatment Update
Incontinence Treatment in Transitional Urology
Adolescent Varicocele: To Treat or Not to Treat
Closing Remarks
0730-1500
LS: Semi-Live Surgery
Learning Objectives: At the end of this session, attendees will be able to:
0730-1630
SYMP-12: World Urological Oncology Federation (WUOF) Symposium - Advances in Systemic Therapeutics
Welcome & Introductions
Framing of Theme
Session One | Advanced Prostate Cancer
Optimizing Treatment for Locally Advanced Prostate Cancer
Molecular Imaging to Assess PCa Biology and Differentiation
Genomics and Novel Markers for Identification of Inherited PCa Risk
Precision Medicine in CRPC
ADT and Cardiovascular Disease - Myths and Misperceptions
Discussion
Coffee Break
Session Two | Bladder Cancer
Genomics of Bladder Cancer
Sexual Dimorphism in Bladder Cancer - Implications for Management
Tri-modal Therapy for MIBC: Role of the Urologic Oncologist
Proteogenomics and Predicting Sensitivity to Chemotherapy
Regionalization of Bladder Cancer Care
Combined Radiation with Checkpoint Inhibitors in Bladder Cancer
Bladder and Upper Tract Urothelial Cancer - Fraternal Twins or Distant Cousins
Discussion
Leadership Transition – Succession of WUOF Chair
Working Lunch Meal vouchers required for all registered attendees
Session Three | Kidney Cancer
Population Screening for Kidney Cancer
Surgical Insights for Management of Non-Clear Histology of RCC
Molecular Biomarkers in RCC and Personalized Therapy
Current Status of Cytoreductive Nephrectomy in the IO Era
Immune Checkpoint Inhibitor Combination Therapy in Primary Metastatic Clear-Cell RCC
Nephrectomy in the Treatment Sequence of Metastatic RCC
Discussion
Session Four | PCA Localized
Getting Into and Under the ‘Hood of Prostate Cancer Racial Disparities
Micro-Ultrasound in the Detection and Staging of Prostate Cancer
Focal Therapy: Clinical Trials to Clinical Practice
How to Define Success After Focal Therapy
Discussion
0800-1500
TIPS-01: SIU Tips and Tricks Session - SIU Academy & SIU Journal
Learning Objectives: At the end of the SIU Academy session, attendees will be able to: At the end of the SIU Journal session, attendees will be able to:
SIU Academy
Social Media as an Educational Tool
Cons
Pros
Consensus
Developing a Telemedicine program: Challenges and Considerations
Training in Urology in the Era of CoVID-19 and Beyond
SIU Scholarships and Training Opportunities
Equity and Inclusion in Urological Training
Panel Discussion
Break
SIU Journal
Introduction
Urologic Publishing in 2021
Q&A
The Perfect Journal
Q&A
Caveat Emptor: Pseudojournals in Urology
Q&A
The Perfect Paper
Q&A
The Perfect Review
Q&A
1000-1200
SYMP-13: Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
To foster a Urologic Oncology session showing the latest advances in prostate, kidney, and bladder cancers with a perspective from an active Urologist in the CAU. To improve the understanding of an organ sparing approach the latest advances in prostate, kidney, and bladder cancers.
Welcome
Predictive Significance of MRI-Targeted Biopsy for Pathological and Oncological Outcomes
Surgical Quality Assessment in Radical Prostatectomy. Lessons from Patient Reported Outcomes
The Impact of 3-D Model and Improved Imaging in Renal Cancer Surgery
Recent Evolution in Localized Bladder Cancer Treatment
Recent Evolution in Advanced Bladder Cancer Treatment
Discussion
Conclusion
1000-1200
SYMP-14: Arab Urology Around the World (AAU) Symposium
Welcome Remarks
Endo of Stone Age
Robotic Management of Urolithiasis
Lithotripsy in Percutaneous Nephrolithotomy
Laser Prostatectomy: Developing Countries’ Perspectives
Management of Glans Deformities Following Penile Prosthesis Insertion
Q&A / Discussion
Difficult Surgical Decisions in RCC
Practice-Changing Advances in Bladder Cancer in 2021
Current Perspectives in the Management of Upper Tract Urothelial Carcinoma
Urology Training in the Arab World: Example from Kuwait Institute for Medical Specialization (KIMS)
Closing Remarks
1000-1300
SYMP-16: Joint SIU-Federation of ASEAN Urological Associations (FAUA) Session
Welcome Remarks
Part 1: Reconstructive Surgery in Urology - Establishing Reconstructive Urology Service in South East Asia (SEA)
Reconstructive Urology Conundrum in Subsaharan Africa
Collaboration in Reconstructive Urology for South East Asia (SEA)
The Challenge in Establishing Reconstructive Service in Daily Practice
How to Start and Learn from Mistakes in Reconstructive Urology
Part 2: Transplant Urology Services
Laparoscopy Donor Nephrectomy
Early Urological Complications of Live Related Renal Transplant: How to Prevent and Solve Them
Transplant Program in Malaysia
Robot Assisted Laparoscopic Living Donor Nephrectomy at Cho Ray Hospital
Part 3: Laparoscopic and Robotic Surgery in Urology in SEA
Robotic Prostatectomy: Worth the Cost?
Singapore Experience with Retzius Sparing Radical Prostatectomy: Why I Stopped
Current Status of Robotic Uro-oncological Surgery in Thailand
Early Experience of Robotic Assisted Lap RPLND
Closing Remarks
1300-1500
SYMP-15: Iranian Urological Association (IUA) Symposium
Bladder Cancer: Peri-operative Considerations in Radical Cystectomy
Bladder Cancer: Neo-adjuvant Treatments
Q&A
Adrenal Mass: Diagnosis and Preoperative Evaluation
Laparoscopy for Adrenal Surgery
Q&A
Panel: Nightmares in Endourology
1300-1500
SYMP-17: International Neuro-Urology Society (INUS) Symposium
Pathophysiology of Neurogenic Lower Urinary Tract Dysfunction and Its Terminology – An Update
the Role of Urodynamics in Neurogenic Lower Urinary Tract Dysfunction
Management Strategies for the Most Frequent Types of Neurogenic Lower Urinary Tract Dysfunction in 2021
Discussion
Neurogenic Urinary Incontinence - Different Pathophysiologies, Different Treatment Strategies
Discussion
Refractory OAB: Electrical Neuromodulation vs. Botulinumtoxine A – A Point-and-Counterpoint Discussion
Discussion & Closing
1500-1700
SYMP-18: Hellenic Urological Association (HUA) Symposium - Current Status and Future Directions in the Treatment of RCC
Introduction
Renal Biopsy: Where do We Stand?
Surveillance in Small Renal Masses
NSS for Small Renal Masses (SRMs)
Cytoreductive Nephrectomy in the CARMENA Era
Smashing News in Systemic Therapy
Discussion/Q&A
1500-1700
SYMP-19: EurAsian Urooncology Association (EUA) Symposium
Introduction
The Rationale for Cystectomy in Patients with T1HG Bladder Cancer
Decision/diagnosis of MIBC by whom? Radiologist vs Pathologist vs Urologist.
Robot Assisted Cystectomy and Intracorporeal Diversion
New Trends on Urinary Diversion Choice
Immunotherapy in Bladder Cancer
Closing Remarks
1700-1830
OC: Opening Ceremonies
0730-0900
IC-01: Instructional Course 01 - PCNL Tips/Tricks and Pitfalls
Learning Objectives: At the end of this session, attendees will be able to:
How to Optimize the Patient Pre-Op
Q&A
How to Simply Perform Miniaturized PCNL
Q&A
How to Efficiently and Safely Perform Standard PCNL
The Do's and the Don'ts in Nightmare Cases: Vote for the Best Option!
PCNL in Ectopic Kidney
Q&A
Discussion & Take Home Messages
0755-0900
MC-01: Master Class 01 - Advanced Kidney Cancer
Learning Objectives: At the conclusion of this course, attendees will be able to:
Introduction
New Systemic Therapies in Advanced RCC
Discussion
Nephrectomy as Part of the Sequencing Options in M+RCC with Primary in Place
Discussion
Cases in Advanced RCC – Clinical Practice
Discussion
What Trials Do We Need in Advanced RCC to Improve Outcomes
Discussion
Take-Home Messages
0800-0900
MC-02: Master Class 02 - Refractory Overactive Bladder Syndrome
Introduction
Definition and Evaluation of the Refractory Overactive Bladder: New Drugs in the Armamentarium
Current Efficacy and Limitations of Neuromodulation
Current Efficacy and Limitations of Intravesical Botulinum Toxin: New Ideas for Delivery on the Horizon
Role of Urodynamics in Refractory OAB
Case-Based Discussion
Q&A
Summary
0900-1030
DEMO: Demo Session: Tips and Tricks in fURS
Pre-registration is required for this session This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks. Learning Objectives
0900-1200
INN-01: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
At the end of this session, attendees will be able to:
Welcome and Introduction to Prostate Cancer Diagnostics and the Role of MRI
MRI Workshop
Tutorial: Prostate MRI and PI-RADS
DynaCAD Introduction (Presented by Philips)
Hands-On: MRI Case Analysis DynaCAD - Basic
Tutorial: Pearls & Pitfalls of Reading and Reporting
Hands-On: MRI Case Analysis DynaCAD - Basic-Iterm
Integration of MRI and Fusion Biopsy into the Diagnostic Pathway
Biopsy Workshop
Tutorial: Biopsies Using Prostate MRI
Live & On-Screen Demo by Industry: Advanced Biopsy Equipment
Value and Use of MRI Based Assessment in Treatment Decision and Surveillance of Prostate Cancer
Discussion and Finish
0900-1045
PL-01: Plenary 01
Welcome
Introduction to SIU-Mostafa M. Elhilali Award Lecture
2021 SIU-Mostafa M. Elhilali Award Lecture
2021 Award Winner - Lecture Title: The Butcher, the Baker and the Ice-cream Maker – a Personal Reflection on Prostate Cancer Treatment over the Last Decade
Emirates Urological Society (EUS) Lecture: Oxidative Stress and Male Infertility Learning Objectives:
Pan African Urological Association (PAUSA) Lecture: Challenges and Opportunities in Urethral Reconstruction in Sub Saharan Africa Learning Objectives:
State-of-the-Art Lecture: Genetics of Bladder Cancer Learning Objectives:
State-of-the-Art Lecture: Novel Therapies in RCC and the Impact on Surgery
Late Breaking Abstract Presentation: 3-Year Results from the ROBUST I Study of the Optilume DCB
1045-1115
Break
1045-1245
TIPS-02: SIU Tips and Tricks Session - SIU uCare
Welcome and Introduction
Learnings from the Stent Registry Study
Opportunities and Challenges in China
Barriers and Enablers in Research in South Africa
Opportunities and Challenges in Taiwan
Opportunities and Challenges in Malaysia
Opportunities for International BPH Studies
Opportunities and Challenges in the Emirates
Opportunities and Challenges in Kenya
Opportunities and Challenges in Greece
Opportunities and Challenges in Iran
The BPH/App uCare Study: An Update
Nested Randomized Trials: A Novel Opportunity for Registry Studies
Closing Remarks
1115-1245
HT-01: Hot Topics 01 - Harnessing Artificial Intelligence (AI) in Urology
Learning Objectives:
Introduction
The Future of Prostate Cancer Imaging; Will AI Play a Role?
The Quantified Surgeon: Predicting Patient Outcomes after Robotic Surgery and Automating Skills Assessment
3D Models to Enhance the Quality of Robotic Assisted Partial Nephrectomy
Ethical and Legal Considerations of Using Artificial Intelligence in Healthcare
Q&A
Closing Remarks
1115-1245
HT-02: Hot Topics 02 - PSMA Theranostics
Learning Objectives: At the conclusion of this course, attendees will be able to:
Introduction
Initial Staging with PSMA
Role of Targeted Salvage Surgery in Biochemical Recurrence (BCR)
Role of Targeted Salvage Radiation and Metastasis-directed Therapy in Biochemical Recurrence (BCR)
Role of PSMA PET in mCRPC and PSMA-RLT
Q&A and Discussion
Take-home Messages
1115-1245
IC-03: Instructional Course 03 - Imaging-Guided Biopsy Diagnostic Pathway in Prostate Cancer
Learning Objectives: At the conclusion of this course, attendees will be able to:
Interpreting Multiparametric MRI
Q&A
What is the Evidence for MRI in the Diagnostic Pathway of Prostate Cancer?
Q&A
Establishing an Image-Guided Biopsy Program
Q&A
Clinical Dilemmas: Case-Based Panel Discussion
Q&A
1115-1245
IC-04: Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Learning Objectives: At the end of this session, attendees will be able to:
Introduction to Novel BPH Therapies
Laser Transurethral Endoscopic Enucleation of the Prostate (EEP)
Q&A
UroLift
Q&A
Rezum
Q&A
Aquablation
Q&A
Stents
Q&A
Closing Remarks
1115-1245
JS-01: Joint SIU-Endourological Society Session
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Session 1: How I Do It – Tips & Tricks, Technique Videos
Nerve Sparing in Radical Prostatectomy
IVC Incision in Level 1 IVC Thrombus Rt Robotic Radical Nephrectomy
Treatment of Upper Tract TCC by FURS - Key Points for Success
ThuLEP - Why I Prefer it
Treatment of Lower Calyx Stone by RIRS
ECIRS – Key Points for Success
Session 2: State-of-the-Art Lectures
Focal Therapy for Renal Tumors
Ureteral Stent – What is the Future?
Session 3 – Debate
Is SWL Out of the Armamentarium of Modern Urology
Yes
No
Holmium Laser for Stone is on Death Bed
Yes
No
Closing Remarks
1115-1245
MP-01: Moderated ePoster Session 01 - Bladder Cancer
1115-1245
MP-02: Moderated ePoster Session 02 - Pediatrics/ Miscellaneous/ Basic Science
1115-1255
JS-02: Joint SIU-International Society of Reconstructive Urology (ISORU) Session
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Hypospadias Surgery
Radiation and Urethral Problems
Gender Reassignment
Vaginoplasty: Preparation, Surgical Anatomy, Follow-up, Oncological Considerations
Vessel Sparing Posterior Urethroplasty
Complex Urethroplasty
Ask the Experts
1245-1315
SYMP-21: Luncheon Symposium: Focal HIFU Therapy in Prostate Cancer: Practice Changes on the Horizon?
At the end of this session, attendees will be able to:
1245-1415
Lunch Break
1400-1700
SYMP-20: Emirates Urological Society (EUS) Programme
Welcome Remarks
Part 1 - Miniaturization in Endourology
Miniaturization in PCNL: CON
Miniaturization in PCNL: PRO
Miniaturization in FURS: Is it The Way to Go?
Miniaturization in Stone Fragments: Is Dusting the Best Choice?
Expert Comments
Part 2 - Men's Health Current and Future Challenges
COVID 19 & Sexual Dysfunction: The Untold Story
Updates in the Management of ED & BPH/LUTS
Anatomical Considerations of IPP Placement: Pitfalls you Can Avoid
Penile Lengthening Strategies at Time of IPP
Expert Comments
Part 3 - BPH/LUTS: Best Clinical Practice
Recent Recommendation in the Management of Male LUTS
MIST of BPH
Echolaser Transperineal Ablation of the Prostate in Outpatient Setting
Post Prostatectomy ED/ incontinence: Surgical Tips & Tricks
Expert Comments
Part 4 - Updates in Prostate Cancer
MRI Imaging of Prostate in Clinical Practice
PET Scanning in Prostate Cancer: Current Recommendation(s)
Patient Selection for Focal Therapy
Management Updates in mHSPC
Expert Comments
Closing Remarks
1415-1545
IC-06: Instructional Course 06 - Minimally-Invasive PCNL (Mini-PCNL): The Way Forward
Learning Objectives: At the end of this session, attendees will be able to:
Percutaneous Access with Ultrasonograpy and Fluoroscopy Guidance
Positioning - Prone or Supine, Single Step Tract Dilation
Use of Various Energy Sources for Stone Fragmentation
Novel Concept-Suction in mini-PCNL - ‘Super mini-perc’
Flexible mini-PCNL and Various Exit Strategies
Case-Based Discussion and Q&A
1415-1545
IC-07: Instructional Course 07 - Focal Therapy for Locoregional or Oligometastatic Recurrence of Prostate Cancer
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Definition of Locoregional or Oligometastatic Recurrence and Case Presentation
Systemic Therapy
Radiotherapy
Surgery
Focal Therapy
Q&A and Discussion
Closing Remarks
1415-1545
MV-01: Master Videos 01 - Genitourinary Fistulae
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Abdominal Approach
Vaginal Approach
Laparoscopic Repair
Robotic Repair
Clinical Cases Discussion
Take-Home Messages
1415-1545
MP-03: Moderated ePoster Session 03 - Infections & Inflammatory Disease
1415-1545
MVP-01: Moderated Video Session 01 - BTO/LUTS, Miscellaneous, Pediatric Urology, Reconstruction
1415-1715
INN: SIU Innovators' Symposium
Learning Objectives: At the end of this session, attendees will be able to:
Part 1: Telemedicine At the end of this session, attendees will be able to:
How to Have a Successful Telemedicine Encounter
Remote Patient Monitoring- How to Optimize Follow-up Strategies in Urology (Oncology vs Non-oncology)
Current Apps Available on The Market and How to Optimize Them
Q&A
Debate on EMR vs Taditional Paper Charts
For Paper Charts
For EMR
Discussion
Part 2: Telementoring At the end of this session, attendees will be able to: Improve knowledge on current mentoring options and facilitation of networking for surgical/medical skills improvement
Current Platforms for Life Surgical Mentoring. Why Should we Promote Telementoring? Pros and Cons
Real-Life Experience on Urology Telementoring - What to Expect?
Q&A
Break
Part 3: Urology Equity - You Cannot Be What You Cannot See: Promoting Equity in Surgery At the end of this session, attendees will be able to:
Current Status of Gender Equity per Continent. Current Analysis as per EAU/SIU/AUA Membership Office
Academic Opportunities: Establishing Mentorship Programmes to Promote Equity
Q&A
Part 4: Planning Clinical Trials
How to Set up a Primary Endpoint for a Clinical Trial in Oncology/Non-Oncology
How to Introduce New Drug/Surgical Treatments in Asia
Strategies to Obtain FDA/EMA Approval: Rationale for Trial Design
1545-1615
Break
1615-1745
IC-08: Instructional Course 08 - Case Based Discussions in Neuro-urology
Learning Objectives: At the conclusion of this course, attendees will be able to:
Introduction
Suprasacal Spinal Cord Injury (SCI) – Case-Based Discussion
Spina Bifida – Case-Based Discussion
Multiple Sclerosis – Case-Based Discussion
Q&A and Discussion
Conclusions
1615-1745
IC-09: Instructional Course 09 - Complex Penile and Urethral Reconstruction in Adults with Prior Hypospadias or Epispadias
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Hypospadias in Adults - Primary Repair
Late Complication of Hypospadias
Re-Doing Epispadias After Failed Surgery in Childhood
Penile Curvature in Adults: Peyronie’s Disease or Congenital?
Phalloplasty: Preparation, Surgical Anatomy, Prosthetics, Follow-up
Q&A and Discussion
Conclusions
1615-1745
MV-02: Master Videos 02 - Endoscopic Surgery for BPH: Compare and Contrast
Learning Objectives: At the conclusion of this course, attendees will be able to:
Aquablation
Urolift: Minimally Invasive Surgical Procedures for LUTS due to BPO: Focus on PUL
Various Endoscopic Enucleation Procedures in Europe
Enucleation by Holmium Laser (HoLEP)
BipolEP
Q&A + Panel Discussion
Take‐home Message
1615-1750
IS-01: Interactive Session 01 - Open Surgery in 2021: When and Why?
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Open Surgery in Bladder Cancer
Case Discussion 1 (with Audience Participation) Bladder Cancer
Open Retroperitoneal Lymph Node Dissection (RPLND)
Case Discussion 2 (with Audience Participation) Testicular Cancer
Open Surgery in Renal Cell Carcinoma (RCC)
Case Discussion 3 (with Audience Participation) Kidney Cancer
Trans-perineal Radical Prostatectomy
Case Discussion 4 (with Audience Participation) Prostate Cancer
Closing Remarks
0700-0800
GA: General Assembly
0730-0900
IC-11: Instructional Course 11 - Bleeding Complications of PCNL - Prevention & Management
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Etiological Factors Leading to Bleeding Complication – Pre, Intra & Post-op
Intra-op Excessive Bleeding – How to Tackle
Post-op Bleeding – Step-by-Step Management
Preventing Steps to Reduce Bleeding Complications in PCNL
Case-Based Discussion
0730-0900
IC-12: Instructional Course 12 - Tools to Make Caring for Pelvic Pain Easier and More Successful for the Urologist
Learning Objectives: At the end of this session, attendees will be able to:
Introduction
Solicitation of Audience Needs
Differential Diagnosis and Triage of Localized Pelvic Pain
Overview of Musculoskeletal Pelvic Pain: Specific Strategies
When Systemic Pain is a Factor: What to Do with These Patients?
Presentation of Difficult Cases by Audience, Q&A
0730-0900
IC-13: Instructional Course 13 - PDE 5 Inhibitor Non-Responders for Erectile Dysfunction
Learning Objectives: At the end of this session, attendees will be able to:
Definition, Incidence, Causes and Aetiopathogenesis
History and Investigations
Medical Treatment- Mono and Polytherapy
Role of Testosterone Deficiency & Replacement Therapy
Minimally Invasive Therapy: Recent Advances in Management
Key Take-home messages, Questions & Answers
0800-0900
MC-03: Master Class 03 - Geriatric Urology
Learning Objectives:
Introduction
How to Evaluate for Pre-operative Frailty? Risk Stratification and its Implications
Detrusor Underactivity in Aging Patients: Evaluation and Management
Urogenital Problems After Menopause: Effects of Oestrogen Replacement
Bladder Outlet Obstruction in the Frail Elderly Patient: My Approach to Management
Take-home Message
0800-1615
NURS: 6th SIU Global Nurses' Educational Symposium
Learning Objectives: At the end of this session, attendees will be able to:
Welcome
Diagnosis and Treatment of Bladder Cancer
Ostomy Management
ERAS: Enhanced Recovery After Surgery
Compliance with Erectile Dysfunction Treatment in Men with Prostate Cancer
Case Study and Clinicians’ Experiences: Nursing Support for Patients with Sexual Dysfunction
Infection Control for Penile Implantation
Break
BPH/LUTS Treatment
Nursing Considerations for Patients with Urinary Symptoms
Nursing Practice Related to Intermittent Catheterization Evidence-Based Practice
Q&A
Abstract Presentations
Case Study: Prostate Cancer Patient Care
Break
The Role of Imaging and Novel Biomarkers to Guide Active Surveillance
Considerations When Performing Prostate Biopsies
Urodynamic Setup
Interpretation and Artifacts
Neuromodulation
Q&A
Therapeutic Modalities and Management of Complex Stone Disease
Operating Room Settings for Stone Surgery (PCNL, Ureteroscopy with Lithotripsy)
Laser Safety in Surgery – General Safety and Specific Requirements in OT
Urosepsis
Use of Chlorhexidine 0.1% for Urethral Cleaning in Pre- and Post- Foley’s Catheter Insertion (Evidence-Based Practice)
Structuring Skin Care to Prevent Incontinence Associated Dermatitis
Comparative Study of Incontinence Associated Dermatitis Treatments- (Evidence-based practice)
Q&A
Meeting Close and Invitation to 7th SIU Global Nurses' Educational Symposium
0900-1030
DEMO: Demo Session: Tips and Tricks in fURS
Pre-registration is required for this session This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks. Learning Objectives
0900-1045
PL-02: Plenary 02
Welcome and SIU Academy Awards Presentation
State-of-the-Art Lecture: Is it Time to Revisit Prostate Cancer Screening? Learning Objectives: At the end of Dr. Emberton's lecture, attendees will be able to:
State-of-the-Art Lecture: The Role for the General Urologist in the Era of Subspecialization
Confederación Americana de Urología (CAU) Lecture: Symptomatic BPH - Present Surgical Options for an Ageing Problem Learning Objectives:
Urological Association of Asia (UAA) Lecture: Technological Evaluation of Renal Puncture for Endoscopic Surgery Learning Objectives:
Panel on Transitional Urology Learning Objectives: At the conclusion of this course, attendees will be able to:
0900-1200
INN-02: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
At the end of this session, attendees will be able to:
Welcome and Introduction to Prostate Cancer Diagnostics and the Role of MRI
MRI Workshop
Tutorial: Prostate MRI and PI-RADS
DynaCAD Introduction (Presented by Philips)
Hands-On: MRI Case Analysis DynaCAD - Basic
Tutorial: Pearls & Pitfalls of Reading and Reporting
Hands-On: MRI Case Analysis DynaCAD - Basic-Iterm
Integration of MRI and Fusion Biopsy into the Diagnostic Pathway
Biopsy Workshop
Tutorial: Biopsies Using Prostate MRI
Live & On-Screen Demo by Industry: Advanced Biopsy Equipment
Value and Use of MRI Based Assessment in Treatment Decision and Surveillance of Prostate Cancer
Discussion and Finish
1045-1115
Break
1115-1245
HT-03: Hot Topics 03 - Future of Urology - Next 20 Years
Learning Objectives: At the end of this session, attendees will be able to:
Developing Robotic Surgery in the Middle East
New Robots
The Rising Importance of Social Media in Urological Education
Improving Education on Endourology
Teleurology Implementation: Practical Points; The UAE Perspective
Checkpoint Inhibitors: Understanding Side Effects
Q&A/Take-Home Messages
1115-1245
IC-02: Instructional Course 02 - Orthotopic Reconstruction: How to Improve Outcomes
Learning Objectives: At the end of this session, attendees will be able to:
Physiologic Basis and Surgical Tips for a Neobladder with Improved Functional Outcome
Tips and Tricks of Nerve Sparing Cystectomy and i-pouch or Ileal Neobladder
How to Improve Outcomes of Open Orthotopic Reconstruction?
Discussion
1115-1245
IC-14: Instructional Course 14 - Nuestros Trucos Técnicos en Cirugía Uretral (Course in Spanish) [Our Technical Tricks in Urethral Surgery]
Learning Objectives: At the end of this session, attendees will be able to:
Introducción
Trucos y Consejos en Patología de Uretra Femenina
Preguntas y respuestas
Estrecheces Secundarias al Cuff de Esfínter Artificial
Preguntas y respuestas
Wednesday, November 10
Please click on the session titles to view the session details when available.
Session will be available live and/or on-demand on [email protected]
Chair: Mohamed Jalloh, Senegal
Mohamed Jalloh, Senegal
E. Oluwabunmi Olapade-Olaopa, Nigeria
0800-0820
0820-0835
0835-0850
0850-0900
Serigne Magueye Gueye, Senegal
Cyril Kamadjou, Cameroon
0900-0920
0920-0935
0935-0950
0950-1000
Co-Chairs: Pankaj Joshi, India / Paksi Satyagraha, Indonesia
0800-0805
Paksi Satyagraha, Indonesia
0805-0814
0814-0823
0823-0832
0832-0841
0841-0855
0855-0904
0904-0913
0913-0922
0922-0931
0931-0940
0940-0955
0955-1000
Paksi Satyagraha, Indonesia
Co-Chairs: Arvind Ganpule, India / Mohammed Lezrek, Morocco
Honorary Chair: Daniel Yachia, Israel
0830-0835
0835-0900
Abdulrahman Al Aown, Saudi Arabia
Sakineh Hajebrahimi, Iran
Wissam Kamal, Saudi Arabia
Rami Labib, United Arab Emirates
Taofiq Olayinka Mohammed, Nigeria
Seshu Mohan Khetavath, India
Egon Ilman Saputra, Indonesia
Mriganka Mani Sinha, United Kingdom
Sai Venkat Manoj Tummala, India
0900-0915
0915-0930
0930-0945
0945-1000
1000-1010
1010-1020
1020-1030
1030-1040
1040-1050
1050-1055
1055-1145
1055-1105
1105-1115
1115-1125
1125-1135
1135-1145
1145-1155
1155-1200
Co-Chairs: Mallikarjuna Chiruvella, India / Keshavamurthy Ramaiah, India
0900-0905
Christopher Evans, United States
0905-0915
0915-0925
0925-0940
0940-0955
0955-1005
1005-1015
1015-1025
1025-1035
1035-1110
Mallikarjuna Chiruvella, India
Arvind Ganpule, India
1110-1150
Keshavamurthy Ramaiah, India
Ravindra Sabnis, India
Panelists
Arun Chawla, India
Arvind Ganpule, India
Kandarp Parikh, India
1150-1200
Chair: Jairam Eswara, United States
1000-1002
1002-1012
1012-1022
1022-1032
1032-1042
1042-1047
1047-1057
1057-1107
1107-1117
1117-1127
1127-1132
1132-1142
1142-1152
1152-1202
1202-1207
1207-1210
Co-Chairs: Badrinath Konety, United States / Li-Ping Xie, People's Republic of China
1300-1345
Nicolae Crisan, Romania
Guohua Zeng, China
1300-1315
1315-1330
1330-1345
1345-1415
Ahmet Yaser Müslümanoğlu, Turkey
Miguel Ramos, Portugal
1345-1400
1400-1415
1415-1445
Patrick Coloby, France
Richard Hautmann, Baden-Württemberg
1415-1430
1430-1445
1445-1515
Mallikarjuna Chiruvella, India
Michael Grasso, United States
1445-1500
1500-1515
1515-1520
Li-Ping Xie, People's Republic of China
Co-Chairs: Patrick Mburugu, Kenya / Saeed R. Samnakay, Kenya
1300-1305
Simon Tanguay, Canada
1305-1320
1320-1335
1335-1350
1350-1405
1405-1420
1420-1435
1435-1450
1450-1505
1505-1510
Saeed R. Samnakay, Kenya
Co-Chairs: Jean de la Rosette, Türkiye / Jurgen Futterer, The Netherlands / Rafael Tourinho-Barbosa, Brazil
1500-1507
Jurgen Futterer, The Netherlands
Rafael Tourinho-Barbosa, Brazil
1507-1522
1522-1537
1537-1552
1552-1607
1607-1622
1622-1637
1637-1645
Jurgen Futterer, The Netherlands
Rafael Tourinho-Barbosa, Brazil
Thursday, November 11
Please click on the session titles to view the session details when available.
Session will be available live and/or on-demand on [email protected]
0730-0735
0735-0743
0743-0751
0751-0759
0759-0807
0807-0815
0815-0823
0823-0838
0838-0846
0846-0952
0852-0900
0859-0900
0730-0735
Sang Don Lee, South Korea
0735-0745
0745-0755
0755-0805
0805-0815
0815-0825
0825-0835
0835-0845
0845-0850
Sang Don Lee, South Korea
Co-Chairs: Jean de la Rosette, Türkiye / Thomas Herrmann, Switzerland
Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada
Sessions 2 and 3, exclusively, will be broadcast live on [email protected]
0730-0755
Laurence Klotz, Canada
0755-0810
Laurence Klotz, Canada
0810-1010
0815-0830
0830-0845
0845-0900
0900-0915
0915-0930
0930-0955
0955-1010
1010-1230
1015-1030
1030-1045
1045-1100
1100-1115
1115-1130
1130-1145
1145-1200
1200-1220
1220-1230
1230-1330
1335-1510
1340-1355
1355-1410
1410-1425
1425-1440
1440-1455
1455-1510
1510-1525
1525-1645
1530-1545
1545-1600
1600-1615
1615-1630
1630-1645
Co-Chairs: Peter Black, Canada / Sean P. Elliott, United States / Stavros Gravas, Cyprus
0800-1000
Sean P. Elliott, United States
Stavros Gravas, Cyprus
0800-0830
Yasser Farahat, United Arab Emirates
0830-0845
0845-0900
0900-0915
0915-0930
0930-1000
1000-1300
1300-1500
1300-1305
1305-1320
1320-1328
1328-1343
1343-1351
1351-1406
1406-1414
1414-1429
1429-1437
1437-1452
1452-1500
Co-Chairs: Andrés Hernández-Porras, Mexico / Alejandro Rodriguez, United States
1000-1005
1005-1023
1023-1041
1041-1101
1101-1119
1119-1137
1137-1155
1155-1200
Chair: Raed Azhar, Saudi Arabia
1000-1009
Yasser Farahat, United Arab Emirates
Rajeev Kumar, India
1009-1021
1021-1033
1033-1045
1045-1057
1057-1109
1109-1121
1121-1133
1133-1145
1145-1157
1157-1209
1209-1215
Chair: Noor Ashani Bin Md. Yusoff, Malaysia
1000-1010
Teng Aik Ong, Malaysia
Arun Chawla, India
Paksi Satyagraha, Indonesia
1010-1025
1025-1040
1040-1055
1055-1110
Mahesh R. Desai, India
Samuel Yrastorza, The Philippines
1110-1125
1125-1140
1140-1155
1155-1210
Simon Tanguay, Canada
Noor Ashani Bin Md. Yusoff, Malaysia
1210-1225
1225-1240
1240-1255
1255-1310
1310-1315
Noor Ashani Bin Md. Yusoff, Malaysia
Co-Chairs: Abbas Basiri, Iran / Mauro Gacci, Italy
1300-1310
1310-1320
1320-1330
1330-1340
1340-1350
1350-1400
1400-1500
Panelists
Anastasios Anastasiadis, Greece
Vincent De Coninck, Belgium
Kandarp Parikh, India
Chair: Helmut Madersbacher, Austria
1300-1315
1315-1330
1330-1345
1345-1400
1400-1415
1415-1420
1420-1440
Thomas Kessler, Switzerland
1440-1500
Co-Chairs: Ioannis Gkialas, Greece / Mohamad Moussa, Lebanon
1500-1505
Mohamad Moussa, Lebanon
1505-1525
1525-1545
1545-1605
1605-1625
1625-1645
1645-1700
Ioannis Gkialas, Greece
Stavros Gravas, Cyprus
Mohamad Moussa, Lebanon
Athanasios (Thanos) Papatsoris, Greece
Petros Sountoulides, Greece
Co-Chairs: Ates Kadioğlu, Türkiye / Ahmet Yaser Müslümanoğlu, Turkey
1500-1510
Ahmet Yaser Müslümanoğlu, Turkey
1510-1530
1530-1550
1550-1610
1610-1630
1630-1650
1650-1700
Ahmet Yaser Müslümanoğlu, Turkey
Friday, November 12
Please click on the session titles to view the session details when available.
Session will be available live and/or on-demand on [email protected]
Co-Chairs: Mohamad Moussa, Lebanon / Athanasios (Thanos) Papatsoris, Greece
0730-0745
0745-0749
0749-0804
0804-0808
0808-0823
0823-0838
0838-0848
0848-0855
Mahesh R. Desai, India
0855-0900
Athanasios (Thanos) Papatsoris, Greece
Co-Chairs: Axel Bex, United Kingdom / Peter Mulders, The Netherlands
0755-0757
Peter Mulders, The Netherlands
0757-0807
0807-0812
0812-0822
0822-0827
0827-0837
0837-0842
0842-0852
0852-0855
0855-0900
Peter Mulders, The Netherlands
Co-Chairs: Sanjay Sinha, India / Alan Wein, United States
0800-0802
Alan Wein, United States
0802-0812
0812-0822
0822-0832
0832-0842
0842-0852
David Manuel Castro Díaz, Spain
0852-0858
0858-0900
Chair: Wissam Kamal, Saudi Arabia
Faculty: Saeed Bin Hamri, Saudi Arabia / Mudhar Nazar Hasan, United Arab Emirates
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom
0900-0905
0905-1040
0905-0917
0917-0922
0922-0957
0957-1005
1005-1040
1040-1055
1055-1130
1055-1105
1105-1130
1130-1145
1150-1200
Honorary Chairs: Christopher Evans, United States / Sanjay Kulkarni, India / Rajeev Kumar, India
0900-0905
0905-0910
0910-0925
0925-0940
At the end of Dr. Kandil's lecture, attendees will be able to:
0940-0955
At the end of Dr. Jalloh's lecture, attendees will be able to:
0955-1010
At the end of Dr. Lerner's lecture, attendees will be able to:
1010-1025
1025-1040
Chair: Laurence Klotz, Canada
1045-1050
1050-1100
1100-1110
1110-1120
1120-1130
1130-1140
1140-1150
1150-1200
1200-1210
1210-1220
1220-1225
1225-1230
1230-1240
1240-1245
Chair: Quoc-Dien Trinh, United States
At the end of this session, attendees will be able to:
1115-1120
1120-1138
1138-1156
1156-1214
1214-1232
1232-1240
1240-1245
Co-Chairs: Tobias Maurer, Germany / Robert Reiter, United States
1115-1117
Robert Reiter, United States
1117-1136
1136-1155
1155-1214
1214-1233
1233-1243
1243-1245
Robert Reiter, United States
Co-Chairs: Peter Black, Canada / Marc Dall'Era, United States
1115-1127
1127-1130
1130-1142
1142-1145
1145-1157
1157-1200
1200-1230
Panelists
Marc Dall'Era, United States
Pieter De Visschere, Belgium
Caroline Moore, United Kingdom
1230-1245
Panelists
Marc Dall'Era, United States
Pieter De Visschere, Belgium
Caroline Moore, United Kingdom
Chair: Dean Elterman, Canada
1115-1120
1120-1132
1132-1136
1136-1148
1148-1152
1152-1204
1204-1208
1208-1220
1220-1224
1224-1236
1236-1240
1240-1245
Chair: Mahesh R. Desai, India
1115-1120
1120-1126
1126-1132
1132-1138
1138-1144
1144-1150
1150-1156
1156-1203
1203-1210
1210-1224
1224-1238
1238-1245
Moderators: Tamer A. Abouelgreed, Egypt / Saeed R. Samnakay, Kenya
Moderators: Brian Birch, United Kingdom / Noor Buchholz, United Arab Emirates
Co-Chairs: Reynaldo Gómez, Chile / Sanjay Kulkarni, India
1115-1118
Sanjay Kulkarni, India
1118-1133
1133-1148
1148-1203
1203-1213
1213-1228
1228-1243
1243-1245
Reynaldo Gómez, Chile
Sanjay Kulkarni, India
Richard Santucci, United States
Chair: Rafael Sanchez-Salas, Canada
Moderator: Franck Bladou, France
Faculty: Pascal Rischmann, France / Martin Schostak, Germany
Co-Chairs: Abdulqadir Alzarooni, United Arab Emirates / Yasser Farahat, United Arab Emirates
1400-1405
Jean de la Rosette, Türkiye
Yasser Farahat, United Arab Emirates
1405-1415
1415-1425
1425-1435
1435-1445
1445-1450
Jean de la Rosette, Türkiye
Yasser Farahat, United Arab Emirates
1450-1500
1500-1510
1510-1520
1520-1530
1530-1535
Mohamed Elkhouly, United Arab Emirates
Abdulqadir Alzarooni, United Arab Emirates
1535-1545
1545-1555
1555-1605
Debora Marchiori, Italy
1605-1615
1615-1620
Mohsen Elmekresh, United Arab Emirates
Yaser Saeedi, United Arab Emirates
1620-1630
1630-1640
1640-1650
1650-1700
1700-1705
Ali Thwaini, United Arab Emirates
Waleed Hassen, United Arab Emirates
1705-1710
Yasser Farahat, United Arab Emirates
Chair: Madhu Sudan Agrawal, India
1415-1435
1435-1450
1450-1500
1500-1515
1515-1525
1525-1545
Chair: Pierre Blanchard, France
1415-1417
1417-1422
1422-1437
1437-1452
1452-1507
1507-1522
1522-1542
Pierre Blanchard, France
1542-1545
Co-Chairs: Sherif Mourad, Egypt / Shrawan Kumar Singh, India
1415-1420
1420-1435
1435-1450
1450-1505
1505-1520
1520-1540
1540-1545
Shrawan Kumar Singh, India
Moderators: Mohsen Elmekresh, United Arab Emirates / Rajeev T P, India
Moderators: Hamdy Abotaleb, United Arab Emirates / Rizwan Hamid, United Kingdom
Co-Chairs: Renu Eapen, Australia / Maria Carmen Mir, Spain
1415-1500
1415-1420
1420-1425
1425-1430
1430-1435
1435-1445
1500-1545
Melanie Aube-Peterkin, Canada
Dean Elterman, Canada
1500-1520
1520-1540
James Porter, United States
1540-1545
1545-1600
1600-1630
1600-1612
1612-1625
1625-1630
1630-1715
1630-1645
1645-1700
1700-1715
Chair: Rizwan Hamid, United Kingdom
1615-1620
1620-1640
1640-1700
1700-1720
1720-1740
1740-1745
Co-Chairs: Marta Bizic, Serbia / Jairam Eswara, United States
Define modalities of hypospadias surgery in adult patients
Recognize complications of hypospadias treatment and different surgical approaches for their resolution
Recognize most important surgical steps in re-do epispadias repair; define and achieve successful outcome
Recognize penile curvature in adults as a consequence of Peyronie's disease or congenital deformity
Conduct good postoperative care and treatment.
1615-1620
Jairam Eswara, United States
1620-1635
1635-1650
1650-1705
1705-1720
1720-1730
1730-1740
Jairam Eswara, United States
1740-1745
Jairam Eswara, United States
Co-Chairs: Athanasios (Thanos) Papatsoris, Greece / Anil Kumar Varshney, India
1615-1630
1630-1645
1645-1700
1700-1715
1715-1730
Dimitrios Staios, Greece
1730-1740
Javier Sanchez Macias, Spain
Vincent Misrai, France
Athanasios (Thanos) Papatsoris, Greece
Dimitrios Staios, Greece
Anil Kumar Varshney, India
1740-1745
Anil Kumar Varshney, India
Co-Chairs: Hassan Abol-Enein, Egypt / Amlesh Seth, India
1615-1620
Amlesh Seth, India
1620-1635
1635-1642
1642-1657
1657-1704
1704-1719
1719-1726
1726-1741
1741-1748
1748-1750
Amlesh Seth, India
Saturday, November 13
Please click on the session titles to view the session details when available.
Session will be available live and/or on-demand on [email protected]
Chair: Ravindra Sabnis, India
0730-0735
0735-0750
0750-0805
0805-0820
0820-0835
0835-0900
Panelists
Michael Borofsky, United States
Jean de la Rosette, Türkiye
Brian Matlaga, United States
Chair: Elise De, United States
0730-0735
0735-0740
0740-0800
0800-0820
0820-0840
0840-0900
Chair: Vipan Bhatia, United Arab Emirates
0730-0745
0745-0800
0800-0815
0815-0830
0830-0845
0845-0900
Co-Chairs: Narmada P. Gupta, India / Sanjay Sinha, India
At the end of this session, attendees will be able to:
0800-0802
0802-0816
0816-0830
0830-0844
0844-0858
0858-0900
Sanjay Sinha, India
Co-Chairs: Hussam Al Nusair, United Arab Emirates / Amparo Gudrun Camacho, United States
0800-0805
Amparo Gudrun Camacho, United States
0805-0830
0830-0850
0850-0910
0910-0935
0935-1000
1000-1015
1015-1030
1030-1055
1055-1105
1105-1115
1115-1120
Marcerey Sison Quejada, United Arab Emirates
1120-1135
Amparo Gudrun Camacho, United States
Mariezl Fonbuena, United Arab Emirates
1135-1150
1150-1250
1250-1315
1315-1340
1340-1350
1350-1400
1400-1410
1410-1415
1415-1440
1440-1455
1455-1510
1510-1535
1535-1545
1545-1555
1555-1605
1605-1610
Marcerey Sison Quejada, United Arab Emirates
1610-1615
Amparo Gudrun Camacho, United States
Chair: Wissam Kamal, Saudi Arabia
Faculty: Mudhar Nazar Hasan, United Arab Emirates
Honorary Chairs: Stavros Gravas, Cyprus / Simon Tanguay, Canada
0900-0915
0915-0930
0930-0945
0945-1000
At the end of Dr. Rodríguez's lecture, attendees will be able to:
1000-1015
At the end of Dr. Hamamoto's lecture, attendees will be able to:
1015-1045
Faculty
Rizwan Hamid, United Kingdom
Dan Wood, United States
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom
0900-0905
0905-1040
0905-0917
0917-0922
0922-0957
0957-1005
1005-1040
1040-1055
1055-1130
1055-1105
1105-1130
1130-1145
1150-1200
Co-Chairs: Zaki Almallah, United Arab Emirates / Sudhir Rawal, India
1115-1130
1131-1142
1142-1154
1154-1209
1209-1222
1222-1234
1234-1245
Sudhir Rawal, India
Chair: Richard Hautmann, Baden-Württemberg
1115-1140
1140-1205
1205-1230
1230-1245
Richard Hautmann, Baden-Württemberg
Arnulf Stenzl, Germany
Chair: Reynaldo Gómez, Chile
1115-1120
1120-1136
1136-1140
1140-1156
1156-1200
1200-1216